Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Royal Marsden NHS Foundation Trust |
---|---|
Information provided by: | Royal Marsden NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT00220051 |
To assess the efficacy and safety of pre-operative capecitabine and oxaliplatin followed by capecitabine with concurrent radiotherapy followed by post-operative capecitabine in the treatment of patients with locally advanced or inoperable rectal cancer.
Condition | Intervention | Phase |
---|---|---|
Rectal Cancer |
Drug: Oxaliplatin, Capecitabine Procedure: Pre operative radiotherapy Procedure: Surgical Resection |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase II Study of Oxaliplatin (Eloxatin) Capecitabine (Xeloda) and Pre-Operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer. |
Estimated Enrollment: | 109 |
Study Start Date: | November 2001 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Locally advanced/ poor prognosis primary rectal cancer defined by MRI criteria of any of the categories below;
Exclusion Criteria:
Study ID Numbers: | 1973 |
Study First Received: | September 19, 2005 |
Last Updated: | October 10, 2006 |
ClinicalTrials.gov Identifier: | NCT00220051 History of Changes |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Antimetabolites Capecitabine Digestive System Neoplasms Rectal Neoplasms Gastrointestinal Diseases Rectal Neoplasm Intestinal Diseases |
Rectal Diseases Intestinal Neoplasms Oxaliplatin Digestive System Diseases Rectal Cancer Gastrointestinal Neoplasms Colorectal Neoplasms |
Antimetabolites Capecitabine Antimetabolites, Antineoplastic Digestive System Neoplasms Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Rectal Neoplasms Gastrointestinal Diseases Intestinal Diseases Rectal Diseases |
Pharmacologic Actions Intestinal Neoplasms Neoplasms Oxaliplatin Neoplasms by Site Digestive System Diseases Therapeutic Uses Gastrointestinal Neoplasms Colorectal Neoplasms |